A recent report by the Support for Advocacy and Training to Health Initiatives Sathi revealed the widespread use of bribes by pharmaceutical companies in India, and how they take advantage of the lax government penalties against such actions. The report is based on in depth interviews with 50 medical representatives, area sales managers, doctors and pharma executives in six cities from last year.
It detailed the prominent use of bribes including cash, expensive smartphones, microwave ovens, foreign trips, petrocards, credit cards and sometimes even prostitutes. These pharmaceutical companies take advantage of the lack of laws designed to deal with this type of corruption. This report follows similar practices being exposed back in August. Undercover reporting by the Bureau of Investigative Journalism revealed that Abbot and Sun Pharma gave high-value gifts to doctors to encourage them not to switch to their competitors.
They also offered them extra money as an incentive to buy more antibiotics, leading to the overprescription of these drugs. The numerous reports this year will increase the pressure to introduce this legislation. European Commission launches new Biotech and Biomanufacturing Hub. FlyPharma Amsterdam officially announced as contracts are signed with host sponsors.
Prenatal care could be revolutionised suggests studies from BrightHeart. MHRA approve new treatment combo for transplant-ineligible multiple myeloma patients. Study shows widespread bribery in Indian pharmaceutical industry pharmafile November 29, News story Medical Communications India , Indian Pharma , Modi , bribery A recent report by the Support for Advocacy and Training to Health Initiatives Sathi revealed the widespread use of bribes by pharmaceutical companies in India, and how they take advantage of the lax government penalties against such actions.
Conor Kavanagh. News Alerts and Subscriptions. Latest content. FlyPharma Amsterdam officially announced as contracts are signed with host sponsors February 3, Prenatal care could be revolutionised suggests studies from BrightHeart January 31, MHRA approve new treatment combo for transplant-ineligible multiple myeloma patients January 30, Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site.
